隶属于 alx oncology holdings, inc.
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
相关临床试验
27
16 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
2015
进行中（未招募）
16
59.3%
已完成
2
7.4%
招募中
6
22.2%
暂停
1
3.7%
终止
2
7.4%
暂无批准数据
暂无资讯文章
